AAV9-Tspyl2 gene therapy retards bleomycin-induced pulmonary fibrosis by modulating downstream TGF-β signaling in mice

Idiopathic pulmonary fibrosis (IPF) is a devastating fibrotic lung disease characterized by scarring and destruction of the lung architecture, with limited treatment options. Targeted gene therapy to restore cell division autoantigen-1 (CDA1) expression may be a potential treatment approach to delay...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shijie, Tong, Xiang, Liu, Sitong, Huang, Jizhen, Zhang, Li, Zhang, Tianli, Wang, Dongguang, Fan, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313802/
https://www.ncbi.nlm.nih.gov/pubmed/37391440
http://dx.doi.org/10.1038/s41419-023-05889-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313802/
https://www.ncbi.nlm.nih.gov/pubmed/37391440
http://dx.doi.org/10.1038/s41419-023-05889-8

Ejemplares similares